Tower Research Capital (TRC)’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-8
| Closed | – | – | 6794 |
|
|
2022
Q4 | $0 | Buy |
+8
| New | – | ﹤0.01% | 6950 |
|
|
2020
Q3 | – | Sell |
-42
| Closed | -$7K | – | 5301 |
|
|
2020
Q2 | $7K | Hold |
42
| – | – | ﹤0.01% | 4189 |
|
|
2020
Q1 | $6K | Sell |
42
-101
| -71% | -$14.4K | ﹤0.01% | 2270 |
|
|
2019
Q4 | $47K | Buy |
143
+135
| +1,688% | +$44.4K | ﹤0.01% | 1384 |
|
|
2019
Q3 | $4K | Buy |
+8
| New | +$4K | ﹤0.01% | 3499 |
|
|
2019
Q1 | – | Sell |
-16
| Closed | -$6K | – | 4589 |
|
|
2018
Q4 | $6K | Buy |
+16
| New | +$6K | ﹤0.01% | 2852 |
|
|
2018
Q3 | – | Sell |
-20
| Closed | -$17K | – | 4472 |
|
|
2018
Q2 | $17K | Buy |
20
+15
| +300% | +$12.8K | ﹤0.01% | 2534 |
|
|
2018
Q1 | $7K | Sell |
5
-23
| -82% | -$32.2K | ﹤0.01% | 2627 |
|
|
2017
Q4 | $41K | Buy |
+28
| New | +$41K | 0.01% | 1491 |
|
|
2017
Q2 | – | Sell |
-2
| Closed | -$6K | – | 3886 |
|
|
2017
Q1 | $6K | Buy |
+2
| New | +$6K | ﹤0.01% | 2141 |
|
|
2016
Q4 | – | Hold |
0
| – | -$1K | – | 4665 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 3438 |
|
|
2016
Q2 | – | Sell |
-3
| Closed | -$6K | – | 5248 |
|
|
2016
Q1 | $6K | Buy |
3
+1
| +50% | +$2K | ﹤0.01% | 2596 |
|
|
2015
Q4 | $5K | Sell |
2
-11
| -85% | -$27.5K | ﹤0.01% | 3061 |
|
|
2015
Q3 | $30K | Buy |
+13
| New | +$30K | ﹤0.01% | 1408 |
|